Thomas Rowland
Patrimonio netto: 3 M $ in data 31/07/2026
Patrimonio netto: 3 M $ in data 31/07/2026
Thomas Andrew Rowland worked at Ventrus Biosciences, Inc. from 2007 to 2012 as Secretary, Director & Chief Business Officer.
Other former positions include Director-Marketing at Aptalis Pharma US, Inc., Marketing Director at Scandipharm, Inc., Vice President-Commercial Development at Alnara Pharmaceuticals, Inc., Vice President-Sales & Marketing at Solvay Pharmaceuticals, Inc., Principal at UCB Pharma, Inc., and Vice President-Commercial Operations at Arbor Pharmaceuticals LLC.
Education includes an undergraduate degree from Metropolitan State University of Denver, conferred in 1989.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the developing, manufacturing and marketing of generic pharmaceutical products 0,17% | 12/05/2026 | 38.271 ( 0,17% ) | 3 M $ | 31/07/2026 |
| Società | Posizione | Fine |
|---|---|---|
Ventrus Biosciences, Inc.
Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets phamaceutical products | Presidente | 07/11/2011 |
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research, development & commercialisation of pharmeceutical and biotechnology products | Corporate Officer/Principal | - |
Scandipharm, Inc.
Scandipharm, Inc. Medical DistributorsDistribution Services Distributes gastrointestinal and nutritional drug products, as well as other products related to the treatment of cystic fibrosis | Vendite & Marketing | - |
Arbor Pharmaceuticals LLC
Arbor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products which focuses on cardiovascular, hospital and pediatric markets | Presidente | - |
Aptalis Pharma US, Inc.
Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Markets pharmaceutical products for the treatment of gastrointestinal diseases and disorders | Vendite & Marketing | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Arbor Pharmaceuticals LLC
Arbor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products which focuses on cardiovascular, hospital and pediatric markets | Health Technology |
Ventrus Biosciences, Inc.
Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets phamaceutical products | Health Technology |
Aptalis Pharma US, Inc.
Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Markets pharmaceutical products for the treatment of gastrointestinal diseases and disorders | Health Technology |
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of metabolic diseases | Health Technology |
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Scandipharm, Inc.
Scandipharm, Inc. Medical DistributorsDistribution Services Distributes gastrointestinal and nutritional drug products, as well as other products related to the treatment of cystic fibrosis | Distribution Services |
Metropolitan State University of Denver
Metropolitan State University of Denver Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research, development & commercialisation of pharmeceutical and biotechnology products | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale